Questions :

Will the Minister of AYUSH be pleased to state:

• whether Government has taken steps to encourage research to develop Ayurvedic medicines for various diseases in the country;
• if so, the details thereof;

• whether there is a plan to develop such research centres in Haryana also;

• the number of diseases for which drugs have been developed during the last three years, the details thereof; and
• the provisions made by Government to check the quality of these drugs?

ANSWER

THE MINISTER OF AYUSH (SHRI SARBANANDA SONOWAL)

• Yes, Government of India, Ministry of Ayush has set up Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous organization for undertaking, coordinating, formulating, developing, and promoting research on scientific lines in Ayurvedic The research activities are carried out through its 30 Institutes/Centres/Units located all over India and through collaborative studies with various Universities, Hospitals, and Institutes.
• The research activities of the CCRAS include medicinal plant research (Medico- ethno botanical survey, pharmacognosy and tissue culture), Drug Standardization, Pharmacological Research, Clinical Research, Literary Research & Documentation and other outreach activities. The Council is also conducting Clinical trials for validation of Classical Ayurvedic formulations and for new Ayurvedic drug development adopting prevalent guidelines such as Good Clinical Practices Guidelines for ASU drugs (GCP-ASU), Ministry of Ayush and Ethical guidelines for Bio-Medical Research (ICMR), WHO guidelines for traditional medicines etc. as per requirement. Since inception, the Council has developed various Ayurvedic drugs through Drug Development process.

• There is no plan to develop a research centre in
• From the past three years, CCRAS is in process of developing various Ayurvedic formulations for diseases like: Dengue, Migraine, improving quality of life in Cancer patients, Mental Retardation in Children, Geriatric Health, Conjunctivitis, Cancer, Diabetes, Asthma, Filariasis, Occupational Stress, ATT induced Hepatotoxicity, Non-alcoholic fatty liver diseases, Antenatal Care (Anemia), Antenatal Care (Oedema), Repurposing for Malaria Mild to Moderate COVID – Details are given at Annexure.
• The Drugs & Cosmetics Act, 1940 and Drugs & Cosmetics Rules, 1945 have exclusive regulatory provisions for Ayurvedic, Siddha and Unani (ASU) Enforcement of the legal provisions pertaining to quality control and issuance of drug license of Ayurveda, Siddha, Unani and Homoeopathy drugs, is vested with the State Drug controllers/State Licensing Authorities appointed by the concerned State/Union Territory Government.

******

Annexure

Drugs under development by CCRAS during last three years